Alembic to expand their U.S. commercial portfolio with FDA-approved PIVYA for the treatment of women with uncomplicated ...

Carlyle Group (CG) is reportedly set to sell up to a 10% stake in Indian drugmaker Piramal Pharma, in a deal that could fetch ...

Private equity firm Carlyle Group is preparing to offload up to a 10% stake in India's Piramal Pharma , online news portal ...

The acquisition is being done by Alembic Pharmaceuticals, Inc, the company's US subsidiary, Alembic said in a statement.

Why did two private equity firms with more than $460 billion under management want a little old gene therapy biotech called ...

New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to ...

Protagonist is directly going up against Eli Lilly, which is advancing retatrutide, also a triple-G agonist, in a Phase II ...

"Piramal Pharma announces $90m investment to expand US sites" was originally created and published by Pharmaceutical ...